Literature DB >> 6292786

Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons.

M H Thiébot, M Hamon, P Soubríe.   

Abstract

In chronically implanted awake rats, microinjections of chlordiazepoxide (5 x 10(-7) M) into the dorsal raphé significantly attenuated the inhibition of lever-pressing for food elicited by a signal of punishment. This effect is abolished by prior application of 5,7-dihydroxytryptamine into the dorsal raphé (3 weeks after the infusion of the neurotoxin, dorsal raphé tryptophan hydroxylase activity was reduced to 25% of control values). Furthermore, the disinhibitory effect of intra raphé chlordiazepoxide can be mimicked or potentiated by intra raphé dorsalis application of serotonin (10(-7) or 10(-8) M, respectively). Further evidence for a crucial interaction between benzodiazepines and serotoninergic processes are provided by in vitro experiments showing that chlordiazepoxide or diazepam (10(-5) M) are able to facilitate the K+-evoked [3H]serotonin release from rat midbrain slices. Finally, a high density of [3H]flunitrazepam binding sites was found in the dorsal (and the median) raphé nucleus, the Kd and Bmax values being not altered by prior infusion of 5,7-dihydroxytryptamine. These in vitro data suggest possible means by which intra raphé (and perhaps peripherally administered) benzodiazepines may affect the activity of serotoninergic neurons and thereby produce their effects on experimental anxiety.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292786     DOI: 10.1016/0306-4522(82)90139-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).

Authors:  J D Lane
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

Authors:  G A Higgins; B J Jones; N R Oakley; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Anxiolytic effects of benzodiazepines in amygdala-lesioned rats.

Authors:  E Yadin; E Thomas; C E Strickland; H L Grishkat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Proceedings of the British Pharmacological Society. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

5.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat.

Authors:  M H Thiébot; P Soubrié; M Hamon; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Social stress alters inhibitory synaptic input to distinct subpopulations of raphe serotonin neurons.

Authors:  LaTasha K Crawford; Shumaia F Rahman; Sheryl G Beck
Journal:  ACS Chem Neurosci       Date:  2013-01-08       Impact factor: 4.418

8.  Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

Authors:  H Hodges; S Green; B Glenn
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.

Authors:  D Charrier; L Dangoumau; A J Puech; M Hamon; M H Thiébot
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

10.  Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.

Authors:  B Costall; M E Kelly; R J Naylor; E S Onaivi; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.